research use only
Cat.No.S6821
|
In vitro |
DMSO
: 21 mg/mL
(50.68 mM)
Ethanol : 7 mg/mL Water : 2 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 414.32 | Formula | C18H16BrN5S |
Storage (From the date of receipt) | 3 years -20°C(in the dark) powder |
|---|---|---|---|---|---|
| CAS No. | 298-93-1 | -- | Storage of Stock Solutions |
|
|
| Synonyms | MTT, Tetrazolium bromide, Methylthiazolyldiphenyl-tetrazolium bromide, Methylthialazole Tetrazolium | Smiles | CC1=C(SC(=N1)[N+]2=NC(=NN2C3=CC=CC=C3)C4=CC=CC=C4)C.[Br-] | ||
| In vitro |
1.Preparation of MTT working solution |
References |
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06364137 | Not yet recruiting | Anxiety Disorders|Mood Disorders |
Stanford University|National Institute of Mental Health (NIMH)|MainSquare Co. (dba ''Teleo'') |
July 1 2024 | Not Applicable |
| NCT06376500 | Not yet recruiting | Transcranial Direct Current Stimulation|Post-Concussion Syndrome|Functional Magnetic Resonance Imaging|Magnetic Resonance Spectroscopy |
The Hong Kong Polytechnic University |
June 2024 | Not Applicable |
| NCT05516472 | Not yet recruiting | Kidney Stones |
Joshua Stern|University of Minnesota|Albert Einstein College of Medicine|Litholink Corporation|Intermountain Health Care Inc. |
April 2024 | Early Phase 1 |
| NCT06382480 | Recruiting | Overweight|Obesity|Prediabetes|Type 2 Diabetes |
German Institute of Human Nutrition|Charite University Berlin Germany|Helmholtz Center Munich|Hasso Plattner Institute Potsdam Germany |
April 12 2024 | Not Applicable |
| NCT06197308 | Recruiting | Primary Sclerosing Cholangitis |
University of Minnesota |
March 1 2024 | Early Phase 1 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.